Work

Study to Evaluate the Safety, Efficacy, and Duration of Dual Antiplatelet Therapy in Coronary Artery Disease Patients

Year: 2025

Type: article

Abstract: Coronary artery disease (CAD) is a leading cause of mortality globally, characterized by the formation of atherosclerotic plaques that impede blood flow to the myocardium. Dual antiplatelet therapy (DAPT), combining aspirin with a P2Y12 inhibitor, is essential for reducing ischemic events post-coronary stenting. This paper aimed to evaluate the safety, efficacy, and optimal duration of DAPT with ECOSPRIN+TICAGRELOR versus ECOSPRIN+CLOPIDOGREL in CAD patients.

Source: Journal of Cardiology and Cardiovascular Medicine

DOI: 10.29328/journal.jccm.1001206

Authors: Aashritha Mary Dodda, Oggu Archana, Shiksha Netam, Bommagani Pavan Kumar, Emani Sai Sri Jayanthi

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4408532570

FWCI:

Cites: 7

Cited by:

Related to: 10